Company Profile
PolyNovo designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong.
The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction.
Its portfolio also includes Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes, NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds, and plastics and reconstructive device products. Incorporated in 1998 and headquartered in Port Melbourne, Australia, PolyNovo was formerly known as Calzada Limited before rebranding in November 2014.